Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Kehong ZhangRoss J Baldessarini

Abstract

Genetic studies suggest that dopamine D(4) receptor polymorphism is associated with attention deficit hyperactivity disorder (ADHD). We recently reported that motor hyperactivity in juvenile male rats with neonatal 6-hydroxydopamine lesions of the central dopamine system can be reversed by dopamine D(4) receptor-selective antagonists. In this study, effects of such lesions on D(4) as well as other dopamine receptors (D(1) and D(2)) were autoradiographically quantified at selected developmental stages. Neonatal lesions resulted in motor hyperactivity at postnatal day (PD) 25, but not at PD 37 or 60. Correspondingly, D(4) receptor levels in lesioned rats were substantially increased in caudate-putamen and decreased in nucleus accumbens at PD 25, but not at PD 37 or 60. Neonatal lesions also led to relatively minor changes in D(1) and D(2) receptor binding in various forebrain regions. However, the time-course of lesion-induced motor hyperactivity correlated only with changes in D(4), but not D(1) and D(2) receptors. These results further support the hypothesis that D(4) receptors may play a pivotal role in lesion-induced hyperactivity, and possibly in clinical ADHD.

Citations

Mar 25, 2011·Attention Deficit and Hyperactivity Disorders·Thomas A SontagKlaus W Lange
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Albert H C Wong, Hubert H M Van Tol
Apr 2, 2003·Brain Research. Brain Research Reviews·Eugen DavidsRoss J Baldessarini
Aug 29, 2009·Social Cognitive and Affective Neuroscience·Dan T A EisenbergJ Koji Lum
Jul 6, 2010·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·I González-BurgosR Ponce-Rolón
Oct 23, 2008·European Journal of Pharmacology·Feng JinJing-Shan Shi
Sep 24, 2004·Journal of Neurochemistry·Yoshinori MasuoEtsuo Niki
Jul 6, 2007·The European Journal of Neuroscience·Yoshinori MasuoEtsuo Niki
Sep 16, 2014·Parkinsonism & Related Disorders·Bing HanHua Zhao
Mar 28, 2012·Expert Review of Neurotherapeutics·Francis M Crinella
Jan 12, 2007·Behavioral and Brain Functions : BBF·Dan T A EisenbergDavid S Wilson
Dec 3, 2013·Journal of Psychiatric Research·Nina H van MilHenning Tiemeier
Nov 2, 2006·The International Journal of Neuropsychopharmacology·Hans BouwmeesterJan M van Ree
Feb 15, 2005·Brain Research. Brain Research Reviews·George R BreeseBonita L Blake
Feb 2, 2006·Journal of Affective Disorders·Regina C Casper
Apr 24, 2007·Journal of Neuroscience Methods·Theresa Currier ThomasPaul E A Glaser
Dec 17, 2008·Journal of Psychopharmacology·J A MilsteinT W Robbins
Mar 17, 2007·The Journal of Comparative Neurology·Belén GagoAlicia Rivera
Nov 13, 2007·Journal of Neural Transmission·R M KostrzewaR Brus
Nov 4, 2004·Journal of Receptor and Signal Transduction Research·Frank I TaraziRoss J Baldessarini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.